Get the Weekly Intelligence Brief — top committee picks every Sunday.
MZTI · NASDAQ · STOCK

The Marzetti (MZTI) Stock Analysis

Consumer Defensive Updated October 10, 2026
$99.37
52W $97.00 – $176.26
68/100
$2.72B
14.2
0.36
AI Committee Verdict
Buy
68/100
Conviction: High · 83% agreement · 6 analysts
+18.4%
High

Is MZTI Bullish or Bearish?

Bullish. Innellis AI committee rates The Marzetti Company (MZTI) Buy with a composite score of 68/100 , based on 6 analysts with 83% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +6.56 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -13.44 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.75 across 4 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • P/E of 14.1 is inexpensive for the broad market — Value
  • ROE of 18.5% shows genuine earnings power backing the valuation — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • Low leverage (debt-to-equity 0.20) -- balance sheet can absorb a shock — Risk
Bear Case
  • Price structure making lower highs and lower lows — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
68/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 1%
of 72 Consumer Defensive peers
Value Analyst bullish
70 / 100 · High confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 14.1 is inexpensive for the broad market
Growth Analyst bullish
62 / 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst neutral
56 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Risk Analyst bullish
75 / 100 · Moderate confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.20) -- balance sheet can absorb a shock
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
82 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.75 across 4 articles, 14d)
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 67.6 to 68.4.

Analyst-level changes:
  • News Analyst: score 77->82 (+5); +1 bullish signal(s).
  • Value Analyst: +1 bullish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
39.9
Neutral
MACD Histogram
0.371
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Mixed
Bollinger %B
0.21
Inside Bands
Price vs Moving Averages
EMA 9
$100.41 Below
EMA 21
$101.83 Below
EMA 50
$105.53 Below
EMA 200
$125.37 Below

Fundamental Analysis

Valuation
94
Growth
62
Profitability
64
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio 14.2×
P/B Ratio 2.72×
PEG Ratio 0.95
Dividend Yield 4.03%
52W High $176.26
52W Low $97.00
Quality & Growth
ROE 1918.9%
ROA 1503.1%
Gross Margin 2473.2%
Operating Margin 1237.0%
Revenue Growth YoY —
Debt / Equity 0.06
AI Fundamental Assessment
P/E ratio of 14.2 (inexpensive relative to a 15-40x range); Price-to-book of 2.7x; PEG ratio of 0.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 19.2%; Return on assets of 15.0%; Net margin of 9.9%; Gross margin of 24.7%; Current ratio of 2.38 (healthy short-term liquidity); Debt-to-equity of 0.06; Free cash flow per share is positive (7.53); Most recent quarter beat estimates by 2.6%; EPS growth accelerating (-40.5% -> +10.6% QoQ); Average YoY EPS growth of 23.7%; Analyst estimates falling over recent quarters
Get the Full MZTI Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime